Biro FM, Summer SS, Huang B, Chen C, Benoit J, Pinney SM
We hypothesise that selection of region-specific AIs is favoured because mutations in those regions modulate a competitive growth advantage
Some long-term users run it year-round at maintenance doses
M., McHale, K
The rate of weight loss tends to be faster in the first few months and then slows as the body adjusts
The GLP-1 receptor agonist class includes several medications: Semaglutide (brand names Wegovy for weight loss, Ozempic for diabetes) Liraglutide (brand names Saxenda for weight loss, Victoza for diabetes) Tirzepatide (brand name Zepbound for weight loss, Mounjaro for diabetes), which is technically a dual GIP/GLP-1 receptor agonist Dulaglutide (Trulicity, for diabetes) Tirzepatide deserves special mention because it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors